BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28933259)

  • 1. Potential therapeutic implications of miRNAs in osteosarcoma chemotherapy.
    Chen D; Liu D; Chen Z
    Tumour Biol; 2017 Sep; 39(9):1010428317705762. PubMed ID: 28933259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-410 regulates autophagy-related gene ATG16L1 expression and enhances chemosensitivity via autophagy inhibition in osteosarcoma.
    Chen R; Li X; He B; Hu W
    Mol Med Rep; 2017 Mar; 15(3):1326-1334. PubMed ID: 28138700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypoxia-inducible microRNA-488 regulates apoptosis by targeting Bim in osteosarcoma.
    Zhou C; Tan W; Lv H; Gao F; Sun J
    Cell Oncol (Dordr); 2016 Oct; 39(5):463-471. PubMed ID: 27376839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-301a modulates doxorubicin resistance in osteosarcoma cells by targeting AMP-activated protein kinase alpha 1.
    Zhang Y; Duan G; Feng S
    Biochem Biophys Res Commun; 2015 Apr; 459(3):367-73. PubMed ID: 25727016
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 Increases Proliferation and Cisplatin Sensitivity of Osteosarcoma-Derived Cells.
    Vanas V; Haigl B; Stockhammer V; Sutterlüty-Fall H
    PLoS One; 2016; 11(8):e0161023. PubMed ID: 27513462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noncoding RNAs in osteosarcoma: Implications for drug resistance.
    Lin Z; Xie X; Lu S; Liu T
    Cancer Lett; 2021 Apr; 504():91-103. PubMed ID: 33587978
    [TBL] [Abstract][Full Text] [Related]  

  • 7. miR-146b-5p promotes invasion and metastasis contributing to chemoresistance in osteosarcoma by targeting zinc and ring finger 3.
    Xu E; Zhao J; Ma J; Wang C; Zhang C; Jiang H; Cheng J; Gao R; Zhou X
    Oncol Rep; 2016 Jan; 35(1):275-83. PubMed ID: 26549292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Research Progress of MicroRNA in Chemotherapy Resistance of Osteosarcoma.
    Tang Z; Lu Y; Chen Y; Zhang J; Chen Z; Wang Q
    Technol Cancer Res Treat; 2021; 20():15330338211034262. PubMed ID: 34323141
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TGF-β1-induced miR-202 mediates drug resistance by inhibiting apoptosis in human osteosarcoma.
    Lin Z; Song D; Wei H; Yang X; Liu T; Yan W; Xiao J
    J Cancer Res Clin Oncol; 2016 Jan; 142(1):239-46. PubMed ID: 26276504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. miR-382 inhibits tumor growth and enhance chemosensitivity in osteosarcoma.
    Xu M; Jin H; Xu CX; Sun B; Mao Z; Bi WZ; Wang Y
    Oncotarget; 2014 Oct; 5(19):9472-83. PubMed ID: 25344865
    [TBL] [Abstract][Full Text] [Related]  

  • 11. microRNA-143 is associated with the survival of ALDH1+CD133+ osteosarcoma cells and the chemoresistance of osteosarcoma.
    Zhou J; Wu S; Chen Y; Zhao J; Zhang K; Wang J; Chen S
    Exp Biol Med (Maywood); 2015 Jul; 240(7):867-75. PubMed ID: 25576341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD44 is a direct target of miR-199a-3p and contributes to aggressive progression in osteosarcoma.
    Gao Y; Feng Y; Shen JK; Lin M; Choy E; Cote GM; Harmon DC; Mankin HJ; Hornicek FJ; Duan Z
    Sci Rep; 2015 Jun; 5():11365. PubMed ID: 26079799
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Review of microRNA in osteosarcoma and chondrosarcoma.
    Chang L; Shrestha S; LaChaud G; Scott MA; James AW
    Med Oncol; 2015 Jun; 32(6):613. PubMed ID: 25920607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug resistance-related microRNAs in osteosarcoma: Translating basic evidence into therapeutic strategies.
    Chen R; Wang G; Zheng Y; Hua Y; Cai Z
    J Cell Mol Med; 2019 Apr; 23(4):2280-2292. PubMed ID: 30724027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNAs in osteosarcoma: diagnostic and therapeutic aspects.
    Miao J; Wu S; Peng Z; Tania M; Zhang C
    Tumour Biol; 2013 Aug; 34(4):2093-8. PubMed ID: 23797816
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What Is New in the miRNA World Regarding Osteosarcoma and Chondrosarcoma?
    Palmini G; Marini F; Brandi ML
    Molecules; 2017 Mar; 22(3):. PubMed ID: 28272374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deciphering chemoresistance in osteosarcoma: Unveiling regulatory mechanisms and function through the lens of noncoding RNA.
    Chen H; Gong Z; Zhou H; Han Y
    Drug Dev Res; 2024 Apr; 85(2):e22167. PubMed ID: 38444106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of exosomal microRNAs confers doxorubicin resistance in osteosarcoma cells.
    Cai T; Zhang C; Zhan T
    Mol Med Rep; 2023 Apr; 27(4):. PubMed ID: 36866739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. microRNA and Bone Cancer.
    Nugent M
    Adv Exp Med Biol; 2015; 889():201-30. PubMed ID: 26659003
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement and Clinical Aspects of MicroRNA in Osteosarcoma.
    Ram Kumar RM; Boro A; Fuchs B
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27271607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.